At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
Intermittent Exposure to Oxygen via Oro-Nasal Maskdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical and Morphological Effects of Hyperbaric Oxygen Therapy in Patients With Interstitial Cystitis Associated With Fibromyalgia
In Brief
A clinical study evaluating Intermittent Exposure to Oxygen via Oro-Nasal Mask for Fibromyalgia and Interstitial Cystitis. Completed, enrolled 12 participants.
Detailed Summary
The investigators observed 12 fibromyalgia and interstitial cystitis patients undergoing hyperbaric oxygen oxygen treatment in a multiplace pressure chamber for 90 minutes, 40 treatment each, using an oro-nasal mask.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFibromyalgia, Interstitial Cystitis
Countries--
CollaboratorsUniversity of Padova
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJun 2016
Primary CompletionJun 2018
Study CompletionJun 2018
First PostedOct 2018
TodayJul 2026
First PostedOct 2, 2018
Enrollment StartJun 1, 2016
Primary CompletionJun 1, 2018
Study CompletionJun 15, 2018
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 7.8 years ago
Interventions
Intermittent Exposure to Oxygen via Oro-Nasal Maskdevice
Patients were exposed to breathing 100% oxygen at 2 atmospheres absolute (ATA) in a multiplace pressure chamber for 90 minutes using an oro-nasal mask for 40 treatments over a 2 month period.